About
Leadership
Executive Team
Board of Directors
Facilities
State Disclosures
Therapeutic Areas Overview
Central Nervous System
Fibromyalgia
Migraine
Immunology
Organ Transplant Rejection
Gastro-Intestinal Cancers
Infectious Disease
Mpox (Monkey Pox)
Smallpox
Pipeline
Central Nervous System
TNX-102 SL
Immunology
TNX-1500
TNX-1700
Infectious Disease
TNX-801
TNX-4200 CD45
Expanded Access Policy
Medicines
Clinical Trials
News & Events
Press Releases
Tonix in the News
Tonix Sponsored News
Investor Presentations
Scientific Presentations
IR Events
Op-eds
Investors
News & Events
Presentations
Investor Presentations
Scientific Presentations
Program Specific Presentations
Conference Materials
Multimedia
Financial Info
Stock Data
SEC Filings
Governance
Careers
Contact Us
Press Releases
Investors
Investors
Overview
News & Events
Press Releases
Tonix in the News
Tonix Sponsored News
IR Events
Email Alerts
Op-Eds
Presentations
Multimedia
Financial Info
Financial Results
Income Statement
Balance Sheet
Cash Flow
Stock Data
Quote
Charts
Historical Data
Analyst Coverage
Form 8937
SEC Filings
All SEC Filings
Annual Reports
Quarterly Reports
Section 16 Filings
Governance
Board of Directors
Board Committees
Governance Documents
Year
All Years
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
Category
All Releases
Financial Releases
Search terms
Search news
Nov 8, 2010 9:00am EST
TONIX Pharmaceuticals Elects Ernest Mario, PhD, to its Board of Directors
Previous Page
arrow_back
Page
1
…
…
Page
62
Page
63
Page
64
Page
65
Page
66
Page
67
Page
68
Page
69
Page
70
Page
71
rss_feed
News RSS
